Cell Source, Inc.: 10-Q filed 2015-11-16

Name: Cell Source, Inc.: 10-Q filed 2015-11-16
Creator: Cell Source, Inc.

What Cell Source, Inc. reported in its quarterly report filed 2015-11-16 (fiscal Q3 2015): 17 published measures, 47 facts as tagged in accession 0001165527-15-000550.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-16
Fiscal period: fiscal Q3 2015
Accession: 0001165527-15-000550 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	311,559	USD
At 2014-12-31	123,105	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-5,544,718	USD
At 2014-12-31	-3,783,728	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	5,866	USD
At 2014-12-31	19,480	USD
At 2014-09-30	104,087	USD
At 2013-12-31	28,878	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-673,437	USD	92
2015-01-01 to 2015-09-30	-1,800,990	USD	273
2014-07-01 to 2014-09-30	-686,498	USD	92
2014-01-01 to 2014-09-30	-2,492,818	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	2,582	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-9,799,480	USD
At 2014-12-31	-7,998,490	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	1,482	USD
At 2014-12-31	2,127	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-549,138	USD	92
2015-01-01 to 2015-09-30	-1,703,135	USD	273
2014-07-01 to 2014-09-30	-715,298	USD	92
2014-01-01 to 2014-09-30	-2,505,218	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	290,077	USD
At 2014-12-31	120,978	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	9,074	USD	92
2015-01-01 to 2015-09-30	15,830	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	5,856,277	USD
At 2014-12-31	3,906,833	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	549,138	USD	92
2015-01-01 to 2015-09-30	1,703,135	USD	273
2014-07-01 to 2014-09-30	715,298	USD	92
2014-01-01 to 2014-09-30	2,505,218	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	230,587	USD	92
2015-01-01 to 2015-09-30	807,365	USD	273
2014-07-01 to 2014-09-30	401,374	USD	92
2014-01-01 to 2014-09-30	1,034,679	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	118,551	USD	92
2015-01-01 to 2015-09-30	295,770	USD	273
2014-07-01 to 2014-09-30	129,959	USD	92
2014-01-01 to 2014-09-30	675,371	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	23,679,256	shares
At 2014-12-31	23,579,256	shares

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	645	USD	273
2014-01-01 to 2014-09-30	240	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-124,299	USD	92
2015-01-01 to 2015-09-30	-97,855	USD	273
2014-07-01 to 2014-09-30	28,800	USD	92
2014-01-01 to 2014-09-30	12,400	USD	273

Inspect the source

Entity: Cell Source, Inc. / CIK 0001569340
Captured: 2026-09-20T09:20:59.488Z
SEC response SHA-256: a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))